February 27, 2024 · Form 4 insider transaction
LIPPS RANDALL A bought 107,251 shares of Omnicell, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on March 1, 2025. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 5/15; (ii) 8/15; (iii) 11/15; and (iv) 2/15.; The balance is adjusted to reflect 459 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/24.